Randomized double-blind placebo-controlled pharmacodynamic evaluation of ONO-5129 in patients with treatment naive type 2 diabetes mellitus

Trial Profile

Randomized double-blind placebo-controlled pharmacodynamic evaluation of ONO-5129 in patients with treatment naive type 2 diabetes mellitus

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Oct 2012

At a glance

  • Drugs ONO 5129 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Aug 2007 Status changed from in progress to completed.
    • 03 Oct 2006 Status change
    • 28 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top